Related Experiment Video
Updated: Aug 6, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
m6A-methylated circFANCB Promotes Gastric Cancer Progression by Regulating Cellular Ferroptosis Through
Haifeng Wang1, Yan Li2, Tiantian Sun1
1Department of Oncology, The People's Hospital of Beilun District; Beilun Branch of the First Affiliated Hospital of Medical College of Zhejiang University, Ningbo, China.
Circular FANCB (circFANCB) promotes gastric cancer (GC) progression by inhibiting ferroptosis via the miR-454-3p/CEACAM5 pathway. METTL3 enhances circFANCB, suggesting therapeutic targets for GC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Gastric cancer (GC) is a leading cause of cancer-related mortality globally.
- Circular FANCB (circFANCB) is implicated in various cancers, but its role in GC remains unelucidated.
- Understanding novel molecular mechanisms is crucial for developing effective GC therapies.
Purpose of the Study:
- To investigate the role and mechanism of circFANCB in gastric cancer progression.
- To explore the regulatory pathway involving circFANCB, miR-454-3p, and CEACAM5 in GC.
- To determine the influence of METTL3 on circFANCB expression and its impact on GC.
Main Methods:
- circRNA sequencing, qRT-PCR, and functional assays (proliferation, migration, invasion, angiogenesis, ferroptosis).
- In vivo xenograft mouse models and immunohistochemistry.
- MeRIP, RIP assays, and dual-luciferase reporter assays to investigate m6A modification and interactions.
Main Results:
- circFANCB expression was significantly upregulated in GC tissues and cell lines.
- circFANCB knockdown suppressed GC cell proliferation, migration, invasion, angiogenesis, and promoted cell death.
- circFANCB promotes GC progression by upregulating CEACAM5 via sponging miR-454-3p, thereby inhibiting ferroptosis. METTL3 enhances circFANCB expression via m6A modification.
Conclusions:
- circFANCB acts as an oncogenic circRNA in GC by promoting proliferation and inhibiting ferroptosis through the miR-454-3p/CEACAM5 axis.
- METTL3-mediated m6A modification of circFANCB contributes to GC malignancy.
- circFANCB represents a potential therapeutic target for gastric cancer treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Master Transcription Regulators
Abnormal Proliferation